These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1755051)

  • 41. Visceral leishmaniasis in the Sudan: comparative parasitological methods of diagnosis.
    Siddig M; Ghalib H; Shillington DC; Petersen EA
    Trans R Soc Trop Med Hyg; 1988; 82(1):66-8. PubMed ID: 3176153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post kala-azar uveitis.
    Dechant W; Rees PH; Kager PA; Klauss V; Adala H
    Br J Ophthalmol; 1980 Sep; 64(9):680-3. PubMed ID: 7191723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Contribution of the duodenal biopsy in the diagnosis of kala-azar].
    Benhassine ML; Mokrani T; Benyahia B; Bendissari K; Keddari M; Khati B
    Arch Inst Pasteur Alger; 1986; 55():125-30. PubMed ID: 3275397
    [No Abstract]   [Full Text] [Related]  

  • 44. A simple medium without blood modified for successful isolation & cultivation of LD bodies.
    Bhattacharya J; Mukherjee H; Das DC; Hati AK
    Indian J Med Res; 1994 Apr; 99():171-2. PubMed ID: 7927570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report.
    Toran KC; Sah SP; Joshi A; Rani S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outbreak of kala-azar in Bombay.
    Bhatia S; Patel N; Gulhane S; Dongre V; Jijina FF; Pathare AV
    J Postgrad Med; 1995; 41(1):3-4. PubMed ID: 10740690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kala-azar: an endemic focus in Bombay.
    Bhende YM; Purandare NM; Banker DD; Figueredo N; Desai SD
    Indian Physician; 1949 Oct; 8(10):296-304. PubMed ID: 18268800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India.
    Das VN; Pandey K; Singh D; Forwood C; Lal CS; Das P
    J Postgrad Med; 2013; 59(3):226-8. PubMed ID: 24029204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous involvement in a rare case of adult visceral leishmaniasis acquired in Israel.
    Ben-Ami R; Schnur LF; Golan Y; Jaffe CL; Mardi T; Zeltser D
    J Infect; 2002 Apr; 44(3):181-4. PubMed ID: 12099746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seroepidemiology and molecular diversity of Leishmania donovani complex in Georgia.
    Babuadze G; Farlow J; de Koning HP; Carrillo E; Chakhunashvili G; Murskvaladze M; Kekelidze M; Karseladze I; Kokaia N; Kalandadze I; Tsereteli D; Markhvashvili I; Sidamonidze K; Chanturia G; Adeishvili E; Imnadze P
    Parasit Vectors; 2016 May; 9(1):279. PubMed ID: 27177688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Observations on human bone-marrow for Leishmania donovani.
    Rajendran P; Chatterjee SN; Gupta JB
    Indian J Pathol Microbiol; 1989 Oct; 32(4):282-5. PubMed ID: 2632416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
    J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leishmania donovani donovani and Leishmania donovani chagasi as antigens in a direct agglutination assay for the diagnosis of kala-azar.
    Andrade CR; Nascimento AE; Moura PM; Andrade PP
    Braz J Med Biol Res; 1989; 22(5):611-5. PubMed ID: 2620171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Images in clinical medicine. Kala-azar.
    Pantsari MW; Coleman TA
    N Engl J Med; 2003 Oct; 349(14):e13. PubMed ID: 14523156
    [No Abstract]   [Full Text] [Related]  

  • 55. Nerve involvement in Indian post kala-azar dermal leishmaniasis.
    Khandpur S; Ramam M; Sharma VK; Salotra P; Singh MK; Malhotra A
    Acta Derm Venereol; 2004; 84(3):245-6. PubMed ID: 15202852
    [No Abstract]   [Full Text] [Related]  

  • 56. Degree of anemia correlates with increased utilization of heme by Leishmania donovani parasites in visceral leishmaniasis.
    Thakur AK; Bimal S; Singh SK; Gupta AK; Das VN; Das P; Narayan S
    Exp Parasitol; 2013 Nov; 135(3):595-8. PubMed ID: 24076432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
    Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
    Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic problems of kala azar in non-endemic area.
    Datta U; Gupta S; Arora S; Sehgal S
    Indian J Pathol Microbiol; 1987 Jan; 30(1):23-9. PubMed ID: 3315993
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.